发明名称 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1- METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H- PYRROL-1-HEPTANOIC ACID HEMICALCIUM SALT (ATORVASTATIN)
摘要 PROBLEM TO BE SOLVED: To provide the stable form of atorvastation being a medicine for treating hyperlipemia and hypercholesterolemia. SOLUTION: This [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1- methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid (atorvastatin) in a new crystalline form called form I, form II and form IV or their hydrate characterized by X-ray powder diffraction and/or NMR in a solid state, and the medicine composition comprising the compound are provided.
申请公布号 JP2003073353(A) 申请公布日期 2003.03.12
申请号 JP20020008746 申请日期 2002.01.17
申请人 WARNER LAMBERT CO 发明人 BRIGGS CHRISTOPHER A;JENNINGS REX ALLEN;WADE ROBERT A;HARASAWA KIKUKO;ICHIKAWA HAYASHI;MINOHARA KAZUO;NAKAGAWA SHINSUKE
分类号 C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):C07D207/34 主分类号 C07D207/34
代理机构 代理人
主权项
地址